Show simple item record

dc.contributor.authorBlake, Diane R.
dc.contributor.authorMiddleman, Amy B.
dc.date2022-08-11T08:10:12.000
dc.date.accessioned2022-08-23T16:59:21Z
dc.date.available2022-08-23T16:59:21Z
dc.date.issued2017-04-01
dc.date.submitted2017-06-01
dc.identifier.citationPediatr Clin North Am. 2017 Apr;64(2):321-329. doi: 10.1016/j.pcl.2016.11.003. <a href="https://doi.org/10.1016/j.pcl.2016.11.003">Link to article on publisher's site</a>
dc.identifier.issn0031-3955 (Linking)
dc.identifier.doi10.1016/j.pcl.2016.11.003
dc.identifier.pmid28292448
dc.identifier.urihttp://hdl.handle.net/20.500.14038/43562
dc.description.abstractRates of cancers attributable to human papillomavirus (HPV) are rising. A safe and extremely effective vaccine is available to prevent many of these cancers. Studies have shown that health care providers' recommendation to immunize is the most important factor in parents' decision. Parents of all adolescent boys and girls should receive a strong and unequivocal recommendation to vaccinate their child against HPV at the 11- or 12-year-old well child visit. Ideally, adolescents complete their HPV vaccine series by their 13th birthday, leading to greater immune response and protection before most adolescents are exposed to sexually transmitted HPV.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=28292448&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttps://doi.org/10.1016/j.pcl.2016.11.003
dc.subjectHuman papillomavirus
dc.subjectVaccine
dc.subjectCervical cancer
dc.subjectOropharyngeal cancer
dc.subjectNeoplasms
dc.subjectPediatrics
dc.subjectVirus Diseases
dc.titleHuman Papillomavirus Vaccine Update
dc.typeJournal Article
dc.source.journaltitlePediatric clinics of North America
dc.source.volume64
dc.source.issue2
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/peds_pp/133
dc.identifier.contextkey10236411
html.description.abstract<p>Rates of cancers attributable to human papillomavirus (HPV) are rising. A safe and extremely effective vaccine is available to prevent many of these cancers. Studies have shown that health care providers' recommendation to immunize is the most important factor in parents' decision. Parents of all adolescent boys and girls should receive a strong and unequivocal recommendation to vaccinate their child against HPV at the 11- or 12-year-old well child visit. Ideally, adolescents complete their HPV vaccine series by their 13th birthday, leading to greater immune response and protection before most adolescents are exposed to sexually transmitted HPV.</p>
dc.identifier.submissionpathpeds_pp/133
dc.contributor.departmentDepartment of Pediatrics, Division of Adolescent Medicine
dc.source.pages321-329


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record